Some studies have shown that COX-2 expression is increased in most CRC patients, suggesting that COX-2 is closely related to CRC (Wang and Dubois, 2010; Su et al., 2016; Dagallier et al., 2021). This evidence concerns the gene PTGS2 and colorectal carcinoma.